Canton Biologics

CDMO focused on manufacturing of cell based therapy products

placeGuangzhou, Guangdong, China calendar_todayFounded 2016 groups100 employees language cantonbio.com

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 11 times.

YearFilings
20222
20241

Investor mix

6 investors on record; lead investors include SDIC Venture Capital Management.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%
Coming soon